Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT07662239
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bone Sarcoma
- Sarcoma
- Soft Tissue Sarcoma (STS)
Eligibility Criteria
- Sex
- ALL
- Age
- 15 Years - 39 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exercise Triage and Personalized Exercise Program — BEHAVIORAL* Part 1: Completion of the EXCEEDS triage tool to assess physical function and determine appropriate referral to rehabilitation or exercise services. * Part 2: Eligible participants receive a 12-week personalized exercise program, which may be supervised or unsupervised, and includes a Garmin activity monitor, resistance bands, and a stepper machine.
Study Details
This study will evaluate strategies to improve physical function and promote exercise and physical activity in adolescents and young adults (AYAs) with sarcoma. The study will assess the feasibility of a standardized triage system for referring AYAs with sarcoma to appropriate exercise and rehabilitation services, and will also examine changes in physical function and health-related quality of life before and after a 12-week personalized exercise program.
Key Dates
- Start date
- Aug 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Aug 28, 2026
- Completion
- Feb 1, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Exercise Triage and Personalized Exercise ProgramAll participants receive this intervention.
Primary Outcome Measure
Triage Tool Completion Rate [ Time Frame: 2 weeks ]
Central Contacts
- Vinayak Venkataraman, MD617-632-5204
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Vinayak Venkataraman, MD (PRINCIPAL_INVESTIGATOR) |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Vinayak Venkataraman, MD (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | Vinayak Venkataraman, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · ImmVira Pharma Co. Ltd · Gilbert, Arizona
- Video Education With Result Dependent dIsclosureRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts